AI Article Synopsis
- * This case report follows a patient with MEN 1 who had various disease manifestations, including thymic carcinoid, which was treated through surgery and adjuvant radiotherapy.
- * Despite initial treatments, the tumor progressed slowly over the years, leading to the patient undergoing chemotherapy, but ultimately, there is insufficient evidence for effective medical treatments for thymic carcinoid.
Article Abstract
Thymic carcinoid tumours, especially in the context of multiple endocrine neoplasia type 1 (MEN 1), present significant clinical challenges due to their rarity and aggressive nature. This case report describes a complex patient with MEN 1, who suffered from multiple manifestations of the disease, including thymic carcinoid. The tumour was initially resected and treated with adjuvant radiotherapy. Due to slow progression over the years, the tumour was treated with two lines of chemotherapy before the patient succumbed to progressive disease. There is currently limited evidence favoring any specific medical treatment for thymic carcinoid.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728356 | PMC |
| http://dx.doi.org/10.1155/2023/8801080 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!